Literature DB >> 3407479

Transsphenoidal surgery of parasellar pituitary adenomas.

R Fahlbusch1, M Buchfelder.   

Abstract

A series of 147 transsphenoidal operations for parasellar pituitary adenomas performed in a 4.5 year period is presented. The clinical and radiological features of the tumours are described and a new practical classification for the neurosurgeon is introduced. The results of surgery are analyzed with special attention to normalization rates in endocrinologically active adenomas and to the recovery rate of optomotoric nerve lesions in 10 of these cases. While in intra- and parasellar microadenomas the surgical normalization rates are comparable to those not extending beyond the confines of the sella, correction of hormonal oversecretion is only exceptionally observed in invasive parasellar macroadenomas. The prognosis for extraocular nerve palsies was found to be favourable, irrespective of the duration of the palsies before surgical intervention. It is to be stressed that even adenomas invading the cavernous sinus can be totally removed via the transsphenoidal approach.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407479     DOI: 10.1007/bf01401978

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  15 in total

1.  The "cavernous" sinus.

Authors:  M A Bedford
Journal:  Br J Ophthalmol       Date:  1966-01       Impact factor: 4.638

2.  Transsphenoidal microsurgical removal of 250 pituitary adenomas.

Authors:  C B Wilson; L C Dempsey
Journal:  J Neurosurg       Date:  1978-01       Impact factor: 5.115

3.  Complications of trans-sphenoidal surgery.

Authors:  E R Laws; E B Kern
Journal:  Clin Neurosurg       Date:  1976

4.  [Neurosurgical therapy of neuroendocrinologic disorders].

Authors:  R Fahlbusch; M Buchfelder; U Schrell
Journal:  Internist (Berl)       Date:  1985-05       Impact factor: 0.743

5.  Intracranial removal of pituitary adenomas. An evaluation of varying degree of excision from partial to total.

Authors:  W E Stern; U Batzdorf
Journal:  J Neurosurg       Date:  1970-11       Impact factor: 5.115

6.  Department of Ophthalmology, University of Alabama, School of Medicine, Birmingham.

Authors:  L B Kline; J D Acker; M J Post; J J Vitek
Journal:  AJNR Am J Neuroradiol       Date:  1981 Jul-Aug       Impact factor: 3.825

7.  The so-called cavernous sinus: a review of the controversy and its implications for neurosurgeons.

Authors:  J N Taptas
Journal:  Neurosurgery       Date:  1982-11       Impact factor: 4.654

8.  Transsphenoidal surgery for Cushing's disease.

Authors:  R Fahlbusch; M Buchfelder; O A Müller
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

9.  Pituitary apoplexy. A review.

Authors:  R L Reid; M E Quigley; S S Yen
Journal:  Arch Neurol       Date:  1985-07

10.  Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.

Authors:  L W King; M E Molitch; J W Gittinger; S M Wolpert; J Stern
Journal:  Surg Neurol       Date:  1983-03
View more
  30 in total

1.  Endoscopic anatomy and approaches of the cavernous sinus: cadaver study.

Authors:  Bashar Abuzayed; Necmettin Tanriover; Nurperi Gazioglu; Fatma Ozlen; Gursel Cetin; Ziya Akar
Journal:  Surg Radiol Anat       Date:  2010-04-29       Impact factor: 1.246

2.  Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension.

Authors:  O Bynke; J Hillman
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.

Authors:  Samuel S Shin; Matthew J Tormenti; Alessandro Paluzzi; William E Rothfus; Yue-Fang Chang; Hanady Zainah; Juan C Fernandez-Miranda; Carl H Snyderman; Sue M Challinor; Paul A Gardner
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

4.  Tumor T2 signal intensity and stalk angulation correlates with endocrine status in pituitary adenoma patients: a quantitative 7 tesla MRI study.

Authors:  John W Rutland; Puneet Pawha; Puneet Belani; Bradley N Delman; Corey M Gill; Teresa Brown; Khadeen Cheesman; Raj K Shrivastava; Priti Balchandani
Journal:  Neuroradiology       Date:  2020-01-10       Impact factor: 2.804

5.  Surgical management considerations in cystic prolactinomas-a single center case series.

Authors:  Edin Nevzati; Grégoire P Chatain; Steven B Carr; Kevin O Lillehei; Janice M Kerr
Journal:  Endocrine       Date:  2019-11-26       Impact factor: 3.633

6.  Factors predicting pituitary adenoma invasiveness in acromegalic patients.

Authors:  A Rieger; N G Rainov; H Ebel; L Sanchin; K Shibib; C Helfrich; O Hoffmann; W Burkert
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

7.  Tentorial enhancement on MR images is a sign of cavernous sinus involvement in patients with sellar tumors.

Authors:  Y Nakasu; S Nakasu; R Ito; K Mitsuya; O Fujimoto; A Saito
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

8.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.

Authors:  Jian Gong; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; M Beatriz S Lopes; Isa M Hussaini; Edward R Laws
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  Variations in referral patterns for hypophysectomies among pediatric patients with sellar and parasellar tumors.

Authors:  Debraj Mukherjee; Hasan A Zaidi; Thomas A Kosztowski; Aditya Halthore; George I Jallo; Roberto Salvatori; David C Chang; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

10.  Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas.

Authors:  Pietro Mortini
Journal:  Endocrine       Date:  2014-08-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.